Every Upgrade Lab becomes a community meeting place, he said
At the 12-month follow-up : 87.5% of patients reported significant relief defined as 50% reduction in baseline pain scores Mean VAS pain score dropped from 7.2 at baseline to 2.8 at 12 months KOOS (Knee Injury and Osteoarthritis Outcome Score) improved across all subscales: pain, symptoms, activities of daily living, sport/recreation, and quality of life No serious adverse events were reported across the treatment period The durability of the response at 12 months is particularly notable
Ingredients: Water, Sodium Laureth Sulfate, Centella Asiatica Extract (5.1%), Glycerin, Propylene Glycol, Cocamide MEA, Lauramide DEA, Cocamidopropyl Betaine, Glutathione (1,000ppm), Niacinamide (1,000ppm), Citric Acid, Sodium Hyaluronate, Caprylic/Capric Triglyceride, Hydrogenated Lecithin, Glyceryl Stearate, Cholesterol, Nelumbo Nucifera Extract, Artemisia Annua Extract, Oryza Sativa (Rice) Extract, Saccharomyces Ferment, Solanum Melongena (Eggplant) Fruit Extract, Melaleuca Alternifolia (Tea Tree) Leaf Extract, 1,2-Hexanediol, Hydrolyzed Collagen, Beta-Glucan, Dipropylene Glycol, Hippophae Rhamnoides Fruit Extract, Butylene Glycol, Styrene/Acrylates Copolymer, Xanthan Gum, Madecassic Acid, Asiaticoside, Asiatic Acid, Squalane, Polyquaternium-10, Disodium EDTA, Sodium Benzoate, Chlorphenesin, Sodium Chloride
Furthermore, Survodutide will be evaluated in several Phase III studies targeting overweight and obese populations, conditions closely related to MASH
